
IT Security Architect (m/f/d) - Business Applications
- Wien
- Unbefristet
- Vollzeit
- Continuously assess and manage the security and risk posture across our enterprise application portfolio
- Guide IT business partner teams in designing and delivering secure business application solutions
- Define and standardize authorization concepts in support of our IAM initiatives, ensuring consistency across platforms such as SAP, Veeva, and Kinaxis
- Lead the development of integration security standards for APIs, data exchanges, and authentication mechanisms
- Classify business applications and align security controls based on criticality, organizational value streams, and process sensitivity
- Collaborate closely with security, enterprise architecture, infrastructure, and application teams to implement comprehensive cloud and SaaS security models
- Bachelor's or master's degree in computer science, Information Security, or related discipline
- 5+ years of experience in IT Security for enterprise application like SAP, including 2+ years in security architecture
- Knowledge of enterprise/security architecture frameworks (e.g. TOGAF, SABSA) and business capability modeling
- Hands-on with IAM systems and the development of authorization models and role concepts
- Solid understanding of cloud security architectures (AWS, Azure, private/hybrid cloud)
- Strong collaboration, communication and documentation skills in English (German is a plus)
- Proactive, structured and responsible approach to work
- Wide range of tasks in an international setting, flexibility and personal responsibility
- Reliable employer with generous employee benefits and a salary customary in the market.
- Familiar setting of a family-owned enterprise with benefits such as Do & Co staff restaurant, extraordinary staff events and many more:
Octapharma Pharmazeutika Produktionsges.m.b.H.
Oberlaaer Straße 235, 1100 Wien
T: +43 (1) 610 32 - 4299About OctapharmaOctapharma is one of the largest human protein manufacturers in the world, developing and producing human proteins from human plasma and human cell lines. We employ more than 11,000 people worldwide to support the treatment of patients in 120 countries with products across three therapeutic areas: Immunotherapy, Haematology and Critical Care. With seven R&D sites and five state-of-the-art manufacturing facilities in Austria, France, Germany, and Sweden, Octapharma also operates over 195 plasma donation centres across Europe and the US. With four decades of experience, we are committed to advancing patient care worldwide.